Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.

Authors :: Bank PCD
Caudle KE
Swen JJ
Gammal RS
Whirl-Carrillo M
Klein TE
Relling MV
Guchelaar HJ
Source :: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2018 Apr; Vol. 103 (4), pp. 599-618. Date of Electronic Publication: 2017 Oct 10.
Publication Year :: 2018
Abstract: Both the Clinical Pharmacogenetics Implementation Consortium (CPIC) and Dutch Pharmacogenetics Working Group provide therapeutic recommendations for well-known gene-drug pairs. Published recommendations show a high rate of concordance. However, as a result of different guideline development methods used by these two consortia, differences between the published guidelines exist. The aim of this paper is to compare both initiatives and explore these differences, with the objective to achieve harmonization.<br /> (© 2017 American Society for Clinical Pharmacology and Therapeutics.)

Subjects :: Genetic Testing methods
Humans
Netherlands
Practice Patterns, Physicians'
Translational Research, Biomedical methods
Translational Research, Biomedical standards
United States
Pharmacogenetics methods
Pharmacogenetics standards
Practice Guidelines as Topic
Precision Medicine methods
Precision Medicine standards

Full Text Access

Tools